Anika Therapeutics | ANIK - Market Capitalization

Stock Price
15.12
Daily Change
0.17 1.14%
Monthly
1.34%
Yearly
4.35%
Q2 Forecast
14.54

Anika Therapeutics reported $215.1M in Market Capitalization this May of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Abbott USD 178.41B 39.46B Mar/2026
Agenus USD 107M 16M Dec/2025
Agios Pharmaceuticals USD 2.01B 423M Mar/2026
Anika Therapeutics USD 139M 3M Dec/2025
Arrowhead Research USD 9.02B 4.25B Dec/2025
Enanta Pharmaceuticals USD 122M 98M Dec/2024
Halozyme Therapeutics USD 7.91B 664M Dec/2025
Heron Therapeutics USD 238M 7M Dec/2025
Insmed USD 37.12B 6.68B Dec/2025
Integra LifeSciences USD 1.03B 301M May/2026
J&J USD 579.15B 78.91B Mar/2026
Karyopharm Therapeutics USD 956M 821M May/2026
MacroGenics USD 102M 4M Dec/2025
Merit Medical Systems USD 4.11B 1.11B Mar/2026
Sanofi EUR 100.27B 605.48M Mar/2026
Smith & Nephew USD 3.62B 9.7B May/2026
Stryker USD 125.85B 8.57B Mar/2026
Veracyte USD 2.59B 16M May/2026
Xencor USD 1.09B 256M Dec/2025
Zimmer Biomet Holdings USD 17.5B 321M Mar/2026